Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Clinical trial NCT01337167 · COMPLETED

Trial details

NCT number: NCT01337167
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Infections Virus Diseases

Start date: 2011-04-19
Primary completion: 2013-05-09
Enrollment: 1473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.